Skip to main content
. 2020 May 21;222(9):1488–1497. doi: 10.1093/infdis/jiaa268

Figure 1.

Figure 1.

CD8+ (A) and CD4+ (B) T-cell responses to any Ebola virus (EBOV)–specific antigen in survivors of EBOV disease with (n = 19) or without (n = 15) sequelae, defined as joint pain along with ≥2 reported ocular symptoms. (P values calculated with Student t tests.)